APA (7th ed.) Citation

Montefiori, L., Iacobucci, I., Budhraja, A., Moore, J., Baskin-Doerfler, R., DeVries, R., . . . Mullighan, C. (2023). POSTER: ALL-594 Preclinical Assessment of Dual FLT3 and BCL-2 Inhibition in Lineage Ambiguous Leukemia. Clinical lymphoma, myeloma and leukemia, 23, S153. https://doi.org/10.1016/S2152-2650(23)00387-7

Chicago Style (17th ed.) Citation

Montefiori, Lindsey, et al. "POSTER: ALL-594 Preclinical Assessment of Dual FLT3 and BCL-2 Inhibition in Lineage Ambiguous Leukemia." Clinical Lymphoma, Myeloma and Leukemia 23 (2023): S153. https://doi.org/10.1016/S2152-2650(23)00387-7.

MLA (9th ed.) Citation

Montefiori, Lindsey, et al. "POSTER: ALL-594 Preclinical Assessment of Dual FLT3 and BCL-2 Inhibition in Lineage Ambiguous Leukemia." Clinical Lymphoma, Myeloma and Leukemia, vol. 23, 2023, p. S153, https://doi.org/10.1016/S2152-2650(23)00387-7.